BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 12851277)

  • 1. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
    Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
    JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps.
    Yeung K; Barthold D; Dusetzina SB; Basu A
    N Engl J Med; 2020 Aug; 383(6):558-566. PubMed ID: 32757524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unintended consequences of caps on Medicare drug benefits.
    Hsu J; Price M; Huang J; Brand R; Fung V; Hui R; Fireman B; Newhouse JP; Selby JV
    N Engl J Med; 2006 Jun; 354(22):2349-59. PubMed ID: 16738271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will the Medicare prescription drug benefit eliminate cost barriers for older adults with diabetes mellitus?
    Tjia J; Schwartz JS
    J Am Geriatr Soc; 2006 Apr; 54(4):606-12. PubMed ID: 16686870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare beneficiaries' management of capped prescription benefits.
    Cox ER; Jernigan C; Coons SJ; Draugalis JL
    Med Care; 2001 Mar; 39(3):296-301. PubMed ID: 11242323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI; Rascati KL
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings.
    Song H; Adamson A; Mostaghimi A
    JAMA Dermatol; 2017 Aug; 153(8):755-759. PubMed ID: 28453645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription drug spending for Medicare+Choice beneficiaries in the last year of life.
    Fahlman C; Lynn J; Doberman D; Gabel J; Finch M
    J Palliat Med; 2006 Aug; 9(4):884-93. PubMed ID: 16910803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.
    Evans-Molina C; Regan S; Henault LE; Hylek EM; Schwartz GR
    J Am Geriatr Soc; 2007 Jul; 55(7):1038-43. PubMed ID: 17608876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly patients' knowledge of drug benefit caps and communication with providers about exceeding caps.
    Tseng CW; Dudley RA; Brook RH; Keeler E; Hixon AL; Manlucu LR; Mangione CM
    J Am Geriatr Soc; 2009 May; 57(5):848-54. PubMed ID: 19484840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do drug benefits help Medicare beneficiaries afford prescribed drugs?
    Rector TS; Venus PJ
    Health Aff (Millwood); 2004; 23(4):213-22. PubMed ID: 15318583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
    Lillard LA; Rogowski J; Kington R
    Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seniors with chronic health conditions and prescription drugs: benefits, wealth, and health.
    Saver BG; Doescher MP; Jackson JE; Fishman P
    Value Health; 2004; 7(2):133-43. PubMed ID: 15164803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.